Viatris Inc. Stock Analysis & AI Score
Viatris Inc. (VTRS) has an ST Score of 55.0 (B-), driven by its Momentum (A) and held back by its Growth (D-). Analysts rate it Hold with a $21.40 price target (+22.8% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Viatris Inc. (VTRS) has an ST Score of 55.0 (B-), driven by its Momentum (A) and held back by its Growth (D-). Analysts rate it Hold with a $21.40 price target (+22.8% upside).
- Strongest
- MomentumA
- Weakest
- GrowthD-
All factor grades
- MomentumA
- ProfitabilityA-
- ValuationB-
- ForecastB-
- Financial StrengthD
- GrowthD-
- Piotroski7/9
Contact
VTRS stock: frequently asked questions
What is VTRS's ST Score?
Viatris Inc. (VTRS) has an ST Score of 55.0 (B-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is VTRS a buy, hold, or sell?
Analysts rate VTRS a Hold, with a price target of $21.40 (+22.8% vs the current price). Our ST Score grades it B- (55.0/100). The ST Score is a data-driven signal, not a recommendation.
What are VTRS's factor grades?
Valuation B-, Profitability A-, Financial Strength D, Momentum A, Growth D-, Forecast B-.
What is VTRS's valuation grade?
Viatris Inc. (VTRS) earns a valuation grade of B-, measured against Drug Manufacturers - Specialty & Generic peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is VTRS's growth grade?
Viatris Inc. (VTRS) earns a growth grade of D-, measured against Drug Manufacturers - Specialty & Generic peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is VTRS's profitability grade?
Viatris Inc. (VTRS) earns a profitability grade of A-, measured against Drug Manufacturers - Specialty & Generic peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is VTRS's financial strength grade?
Viatris Inc. (VTRS) earns a financial strength grade of D, measured against Drug Manufacturers - Specialty & Generic peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for VTRS?
The average analyst price target for Viatris Inc. (VTRS) is $21.40 from 13 analysts, which is +22.8% versus the recent price of $17.42.
What is VTRS's Piotroski score?
Viatris Inc. (VTRS) has a Piotroski F-Score of 7 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.